• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预测T1N0期结肠癌远处转移发生及预后的列线图:一项基于监测、流行病学和最终结果(SEER)数据库的研究

Nomogram to Predict the Occurrence and Prognosis of Distant Metastasis in T1N0 Colon Cancer: A SEER Data-Based Study.

作者信息

Liu Yunxiao, Zhang Hao, Zheng Mingyu, Wang Chunlin, Hu Zhiqiao, Wang Yang, Xiong Huan, Fan BoYang, Wang Yuliuming, Hu Hanqing, Tang Qingchao, Wang Guiyu

机构信息

Department of Colorectal Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, People's Republic of China.

出版信息

Int J Gen Med. 2021 Nov 30;14:9131-9143. doi: 10.2147/IJGM.S335151. eCollection 2021.

DOI:10.2147/IJGM.S335151
PMID:34876846
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8643170/
Abstract

PURPOSE

Distant metastasis (DM) is relatively rare in T1 colon cancer (CC) patients, especially in those with negative lymph node metastasis. The aim of this study was to explore the main clinical factors and build nomogram for predicting the occurrence and prognosis of DM in T1N0 colon cancer patients.

METHODS

Patients with T1N0 stage CC were collected from the Surveillance, Epidemiology, and End Result (SEER) database. All patients were divided into development and validation cohorts with the 3:1 ratio. Logistic regressions were performed to analyze the clinical risk factors for DM. Cox regression model was used to identify potential prognostic factors for patients with DM. The performance of nomogram was evaluated by concordance index (C-index), calibration curves, receiver operating characteristic (ROC) curves and decision curve analyses (DCAs). Based on cancer-specific survival (CSS), Kaplan-Meier curves were generated and analyzed using Log rank tests.

RESULTS

A total of 6770 patients were enrolled in this study, including 428 patients (6.3%) with DM. Age, size, grade, CEA were independent risk factors associated with DM. Age, grade, CEA, surgery and chemotherapy were independent prognostic factors for CSS. Nomograms were applied and C-index, calibration curves, ROC curves and DCA curves proved good discrimination, calibration and clinical practicability of the nomogram in predicting the occurrence and prognosis of DM in T1N0 CC patients. In the DM nomogram, the AUCs for development and validation cohort were 0.901 (95% CI = 0.879-0.922) and 0.899 (95% CI=0.865-0.940), respectively. The calibration curves (development cohort: S: p = 0.712; validation cohort: S: p = 0.681) showed the relatively satisfactory prediction accuracy. Similarly, the AUCs of the nomogram at 1-, 2-, and 3-year were 0.763 (95% CI=0.744-0.782), 0.794 (95% CI=0.775-0.813), and 0.822 (95% CI=0.803-0.841) for the development cohort, and 0.785 (95% CI=0.754-0.816), 0.748 (95% CI=0.717-0.779) and 0.896 (95% CI=0.865-0.927) for the validation cohort in the CSS nomogram. The C-indices of the development and validation cohort were 0.718 (95% CI=0.639-0.737) and 0.712 (95% CI=0.681-0.743).

CONCLUSION

The population-based nomogram could help clinicians predict the occurrence and prognosis of DM in T1N0 CC patients and provide a reference to perform appropriate metastatic screening plans and rational therapeutic options for the special population.

摘要

目的

远处转移(DM)在T1期结肠癌(CC)患者中相对少见,尤其是在那些淋巴结转移阴性的患者中。本研究的目的是探索主要临床因素并构建列线图,以预测T1N0期结肠癌患者DM的发生及预后。

方法

从监测、流行病学和最终结果(SEER)数据库中收集T1N0期CC患者。所有患者按3:1的比例分为训练队列和验证队列。进行逻辑回归分析DM的临床危险因素。采用Cox回归模型确定DM患者的潜在预后因素。通过一致性指数(C-index)、校准曲线、受试者操作特征(ROC)曲线和决策曲线分析(DCA)评估列线图的性能。基于癌症特异性生存(CSS),绘制Kaplan-Meier曲线并使用对数秩检验进行分析。

结果

本研究共纳入6770例患者,其中428例(6.3%)发生DM。年龄、肿瘤大小、分级、癌胚抗原(CEA)是与DM相关的独立危险因素。年龄、分级、CEA、手术和化疗是CSS的独立预后因素。应用列线图,C-index、校准曲线、ROC曲线和DCA曲线证明列线图在预测T1N0期CC患者DM的发生及预后方面具有良好的区分度、校准度和临床实用性。在DM列线图中,训练队列和验证队列的曲线下面积(AUC)分别为0.901(95%可信区间[CI]=0.879-0.922)和0.899(95%CI=0.865-0.940)。校准曲线(训练队列:S:p = 0.712;验证队列:S:p = 0.681)显示出相对满意的预测准确性。同样,在CSS列线图中,训练队列1年、2年和3年的AUC分别为0.763(95%CI=0.744-0.782)、0.794(95%CI=0.775-0.813)和0.822(95%CI=0.803-0.841),验证队列分别为0.785(95%CI=0.754-0.816)、0.748(95%CI=0.717-0.779)和0.896(95%CI=0.865-0.927)。训练队列和验证队列的C-index分别为0.718(95%CI=0.639-0.737)和0.712(95%CI=0.681-0.743)。

结论

基于人群的列线图可帮助临床医生预测T1N0期CC患者DM的发生及预后,并为该特殊人群实施适当的转移筛查计划和合理的治疗方案提供参考。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bac/8643170/d29e4adf721b/IJGM-14-9131-g0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bac/8643170/79b010d1de62/IJGM-14-9131-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bac/8643170/ec289780f211/IJGM-14-9131-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bac/8643170/4fcf940e3af0/IJGM-14-9131-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bac/8643170/f9f150b29281/IJGM-14-9131-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bac/8643170/44fbd70d923e/IJGM-14-9131-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bac/8643170/f55dd1cd3578/IJGM-14-9131-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bac/8643170/f1586f925009/IJGM-14-9131-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bac/8643170/edbf7482b512/IJGM-14-9131-g0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bac/8643170/93866f248104/IJGM-14-9131-g0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bac/8643170/d29e4adf721b/IJGM-14-9131-g0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bac/8643170/79b010d1de62/IJGM-14-9131-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bac/8643170/ec289780f211/IJGM-14-9131-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bac/8643170/4fcf940e3af0/IJGM-14-9131-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bac/8643170/f9f150b29281/IJGM-14-9131-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bac/8643170/44fbd70d923e/IJGM-14-9131-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bac/8643170/f55dd1cd3578/IJGM-14-9131-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bac/8643170/f1586f925009/IJGM-14-9131-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bac/8643170/edbf7482b512/IJGM-14-9131-g0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bac/8643170/93866f248104/IJGM-14-9131-g0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bac/8643170/d29e4adf721b/IJGM-14-9131-g0010.jpg

相似文献

1
Nomogram to Predict the Occurrence and Prognosis of Distant Metastasis in T1N0 Colon Cancer: A SEER Data-Based Study.预测T1N0期结肠癌远处转移发生及预后的列线图:一项基于监测、流行病学和最终结果(SEER)数据库的研究
Int J Gen Med. 2021 Nov 30;14:9131-9143. doi: 10.2147/IJGM.S335151. eCollection 2021.
2
A clinical model to predict distant metastasis in patients with superficial gastric cancer with negative lymph node metastasis and a survival analysis for patients with metastasis.一种用于预测无淋巴结转移的早期胃癌患者远处转移的临床模型和转移患者的生存分析。
Cancer Med. 2021 Feb;10(3):944-955. doi: 10.1002/cam4.3680. Epub 2020 Dec 22.
3
Development and validation of prognostic nomograms for early-onset colon cancer in different tumor locations: a population-based study.不同肿瘤部位早发性结肠癌预后列线图的建立与验证:基于人群的研究。
BMC Gastroenterol. 2023 Oct 21;23(1):362. doi: 10.1186/s12876-023-02991-1.
4
Risk factors for distant metastasis and prognosis in stage T1 esophageal cancer: A population-based study.T1期食管癌远处转移的危险因素及预后:一项基于人群的研究。
Front Surg. 2023 Jan 6;9:988460. doi: 10.3389/fsurg.2022.988460. eCollection 2022.
5
Construction of webbased prediction nomogram models for cancerspecific survival in patients at stage IV of hepatocellular carcinoma depending on SEER database.基于监测、流行病学和最终结果(SEER)数据库构建用于预测肝细胞癌IV期患者癌症特异性生存的网络预测列线图模型。
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2023 Oct 28;48(10):1546-1560. doi: 10.11817/j.issn.1672-7347.2023.230040.
6
Nomogram predicting cancer-specific survival in elderly patients with stages I-III colon cancer.预测 I-III 期老年结肠癌患者癌症特异性生存的列线图。
Scand J Gastroenterol. 2020 Feb;55(2):202-208. doi: 10.1080/00365521.2020.1720280. Epub 2020 Feb 1.
7
Prognosticators and Prognostic Nomograms for Leiomyosarcoma Patients With Metastasis.转移性平滑肌肉瘤患者的预后预测指标及预后列线图
Front Oncol. 2022 Mar 18;12:840962. doi: 10.3389/fonc.2022.840962. eCollection 2022.
8
A Web-Based Prediction Model for Cancer-Specific Survival of Elderly Patients With Early Hepatocellular Carcinoma: A Study Based on SEER Database.基于 SEER 数据库的老年早期肝细胞癌患者癌症特异性生存的网络预测模型研究。
Front Public Health. 2022 Jan 13;9:789026. doi: 10.3389/fpubh.2021.789026. eCollection 2021.
9
Development and validation of a prognostic nomogram for predicting cancer-specific survival in lymph node-negative elderly esophageal cancer patients: A SEER-based study.基于 SEER 数据库的淋巴结阴性老年食管癌患者生存预后列线图模型的建立与验证
Medicine (Baltimore). 2023 Jul 28;102(30):e34441. doi: 10.1097/MD.0000000000034441.
10
Establishment of nomogram to predict overall survival and cancer-specific survival of local tumor resection in patients with colorectal cancer liver metastasis with unresectable metastases: a large population-based analysis.建立列线图预测不可切除转移灶的结直肠癌肝转移患者局部肿瘤切除后的总生存期和癌症特异性生存期:一项基于大人群的分析
Discov Oncol. 2024 Jul 29;15(1):315. doi: 10.1007/s12672-024-01182-y.

引用本文的文献

1
Nomogram predicting the cancer-specific survival of early-onset colorectal cancer patients with synchronous liver metastasis: a population-based study.基于人群的研究:预测早发性结直肠癌伴同步肝转移患者癌症特异性生存的列线图。
Int J Colorectal Dis. 2022 Jun;37(6):1309-1319. doi: 10.1007/s00384-022-04175-x. Epub 2022 May 7.

本文引用的文献

1
The Role of Primary Tumor Resection in Colorectal Cancer Patients with Asymptomatic, Synchronous, Unresectable Metastasis: A Multicenter Randomized Controlled Trial.原发性肿瘤切除在无症状、同时性、不可切除转移结直肠癌患者中的作用:一项多中心随机对照试验
Cancers (Basel). 2020 Aug 16;12(8):2306. doi: 10.3390/cancers12082306.
2
Individualized prediction of survival benefit from primary tumor resection for patients with unresectable metastatic colorectal cancer.不可切除转移性结直肠癌患者原发灶切除的生存获益个体化预测。
World J Surg Oncol. 2020 Aug 3;18(1):193. doi: 10.1186/s12957-020-01972-y.
3
Risk factors and predictors of lymph nodes metastasis and distant metastasis in newly diagnosed T1 colorectal cancer.
新诊断的 T1 结直肠癌中淋巴结转移和远处转移的危险因素和预测因素。
Cancer Med. 2020 Jul;9(14):5095-5113. doi: 10.1002/cam4.3114. Epub 2020 May 29.
4
The outcome of primary tumor resection in the unresectable stage IV colorectal cancer patients who received the bevacizumab-containing chemotherapy.接受含贝伐单抗化疗的不可切除的IV期结直肠癌患者原发肿瘤切除的结果。
Medicine (Baltimore). 2020 Feb;99(7):e19258. doi: 10.1097/MD.0000000000019258.
5
Cancer statistics, 2019.癌症统计数据,2019 年。
CA Cancer J Clin. 2019 Jan;69(1):7-34. doi: 10.3322/caac.21551. Epub 2019 Jan 8.
6
Management of Pt1 tumours removed by endoscopy during colorectal cancer screening: Outcome and treatment quality indicators.结直肠癌筛查中经内镜切除的 Pt1 肿瘤的管理:结局和治疗质量指标。
Eur J Surg Oncol. 2018 Dec;44(12):1873-1879. doi: 10.1016/j.ejso.2018.09.009. Epub 2018 Oct 16.
7
Quality of life and fear of cancer recurrence in T1 colorectal cancer patients treated with endoscopic or surgical tumor resection.内镜或手术肿瘤切除治疗 T1 结直肠癌患者的生活质量和对癌症复发的恐惧。
Gastrointest Endosc. 2019 Mar;89(3):533-544. doi: 10.1016/j.gie.2018.09.026. Epub 2018 Sep 28.
8
Meta-analysis of oncologic effect of primary tumor resection in patients with unresectable stage IV colorectal cancer in the era of modern systemic chemotherapy.现代全身化疗时代不可切除的IV期结直肠癌患者原发肿瘤切除肿瘤学效应的Meta分析。
Ann Surg Treat Res. 2018 Aug;95(2):64-72. doi: 10.4174/astr.2018.95.2.64. Epub 2017 Jul 30.
9
European cancer mortality predictions for the year 2018 with focus on colorectal cancer.2018 年欧洲癌症死亡率预测,重点关注结直肠癌。
Ann Oncol. 2018 Apr 1;29(4):1016-1022. doi: 10.1093/annonc/mdy033.
10
Prognostic value of lymph node metastasis in patients with T1-stage colorectal cancer from multiple centers in China.中国多中心 T1 期结直肠癌患者淋巴结转移的预后价值。
World J Gastroenterol. 2017 Dec 28;23(48):8582-8590. doi: 10.3748/wjg.v23.i48.8582.